EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Development and validation of a nomogram for identifying prevalent sarcopenia in Chinese patients with Cardiovascular-Kidney-Metabolic Syndrome

Chengjun Yang, Qiaohui He, Haiwen Liang, Junru Song, Zehuai Wen, Xingying Qiu, Xiankun Chen, Huayang Cai

Frontiers in Public Health · 22.07.2026 · 14

DOI: 10.3389/fpubh.2026.1887503 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Frontiers in Public Health, online erschienen am 22.07.2026. Verfasst von Chengjun Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Sarcopenia, Nomograms, Metabolic Syndrome, Cardiovascular Diseases. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia is recognized as a significant comorbidity in patients with Cardiovascular-Kidney-Metabolic (CKM) Syndrome, yet validated prediction models for this population remain lacking. This study aimed to develop and validate a nomogram for predicting sarcopenia risk in Chinese patients with CKM syndrome.

Methods

Data were derived from the China Health and Retirement Longitudinal Study (CHARLS) and an independent hospital dataset. The CHARLS 2015 dataset was split into a training set and an internal validation set; the CHARLS 2011 dataset served as the external validation set; and inpatients from Guangdong Provincial Hospital of Chinese Medicine constituted the hospital validation set. Sarcopenia was diagnosed according to the 2025 Asian Working Group for Sarcopenia criteria. Least absolute shrinkage and selection operator (LASSO) regression combined with multivariable logistic regression was used for predictor selection and model development. Model performance was evaluated by discrimination, calibration, and decision curve analysis (DCA).

Results

Nine predictors were identified: age, smoking status, high-density lipoprotein cholesterol, triglycerides, uric acid, C-reactive protein, hemoglobin, chronic obstructive pulmonary disease, and chronic liver disease. The model achieved area under the curve values of 0.817, 0.808, 0.800, and 0.834 in the training, internal validation, external validation, and hospital validation sets, respectively. Calibration was satisfactory in development cohorts ( p > 0.05), with some calibration drift in external populations. DCA confirmed clinical utility across all datasets.

Conclusion

The developed nomogram incorporating nine accessible predictors demonstrated robust discrimination and clinical applicability for sarcopenia risk assessment in Chinese CKM patients, supporting its use in early screening and individualized intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaNomogramsMetabolic SyndromeCardiovascular DiseasesKidney DiseasesHumansFemaleMaleChinaAgedMiddle AgedPrevalenceLongitudinal StudiesRisk Factors

Stichwörter der Autor:innen

Cardiovascular-Kidney-Metabolic SyndromeLASSOROC curvemusclenomogramsarcopenia

Autor:innen und Institutionen

  • The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Center for Clinical Research, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Department of Scientific Research, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
  • Guangdong Provincial Key Laboratory of Research on Emergency in TCM, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

Zitieren

APA

Yang, C., He, Q., Liang, H., Song, J., Wen, Z., Qiu, X., Chen, X., & Cai, H. (2026). Development and validation of a nomogram for identifying prevalent sarcopenia in Chinese patients with Cardiovascular-Kidney-Metabolic Syndrome. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1887503

Vancouver

Yang C, He Q, Liang H, Song J, Wen Z, Qiu X, et al. Development and validation of a nomogram for identifying prevalent sarcopenia in Chinese patients with Cardiovascular-Kidney-Metabolic Syndrome. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1887503

BibTeX
@article{Yang2026,
  author = {Yang, Chengjun and He, Qiaohui and Liang, Haiwen and Song, Junru and Wen, Zehuai and Qiu, Xingying and Chen, Xiankun and Cai, Huayang},
  title = {Development and validation of a nomogram for identifying prevalent sarcopenia in Chinese patients with Cardiovascular-Kidney-Metabolic Syndrome},
  journal = {Frontiers in Public Health},
  year = {2026},
  volume = {14},
  doi = {10.3389/fpubh.2026.1887503}
}
Kostenlos starten →